Biomedical platforms :: realigning the normal and the pathological in late-twentieth-century medicine /
Since the end of World War II, biology and medicine have merged in remarkably productive ways. In this book Peter Keating and Alberto Cambrosio analyze the transformation of medicine into biomedicine and its consequences, ranging from the recasting of hospital architecture to the redefinition of the...
Gespeichert in:
1. Verfasser: | |
---|---|
Weitere Verfasser: | |
Format: | Elektronisch E-Book |
Sprache: | English |
Veröffentlicht: |
Cambridge, Mass. :
MIT Press,
©2003.
|
Schriftenreihe: | Inside technology.
|
Schlagworte: | |
Online-Zugang: | Volltext |
Zusammenfassung: | Since the end of World War II, biology and medicine have merged in remarkably productive ways. In this book Peter Keating and Alberto Cambrosio analyze the transformation of medicine into biomedicine and its consequences, ranging from the recasting of hospital architecture to the redefinition of the human body, disease, and therapeutic practices. To describe this new alignment between the normal and the pathological, the authors introduce the notion of the biomedical platform. Defined as a specific configuration of instruments, individuals, and programs, biomedical platforms generate routines, entities, and activities, held together by standard reagents and protocols. Biological entities such as cell surface markers, oncogenes, and DNA profiles now exist as both normal biological components of the organism and as pathological signs--that is, as biomedical substances. The notion of a biomedical platform allows researchers interested in the development of contemporary medicine to describe events and processes overlooked by other approaches. The authors focus on a specific biomedical platform known as immunophenotyping. They describe its emergence as an experimental system with roots in biology (immunology) and pathology (oncology). They recount how this experimental system was transformed into a biomedical platform initially for the diagnosis of leukemia and subsequently for other diseases such as AIDS. Through this case study, they show that a biomedical platform is the bench upon which conventions concerning the biological or normal are connected with conventions concerning the medical or pathological. They observe that new platforms are often aligned with existing ones and integrated into an expanding set of clinical-biological strategies. |
Beschreibung: | 1 online resource (xiv, 544 pages) : illustrations |
Bibliographie: | Includes bibliographical references (pages 457-525) and index. |
ISBN: | 9780262276870 0262276879 0585480184 9780585480183 |
Internformat
MARC
LEADER | 00000cam a2200000 a 4500 | ||
---|---|---|---|
001 | ZDB-4-EBA-ocm53795840 | ||
003 | OCoLC | ||
005 | 20241004212047.0 | ||
006 | m o d | ||
007 | cr cnu---unuuu | ||
008 | 031126s2003 maua ob 001 0 eng d | ||
010 | |z 2002044414 | ||
040 | |a N$T |b eng |e pn |c N$T |d YDXCP |d OCLCG |d OCLCQ |d N$T |d OCLCQ |d OCLCF |d NLGGC |d OCLCO |d OCLCQ |d TXHLC |d OCLCQ |d TOA |d OCLCO |d AGLDB |d OCLCO |d JBG |d OCLCQ |d OCLCO |d OCLCA |d VNS |d VTS |d OCLCO |d INT |d OCLCQ |d MITPR |d OCLCO |d OCLCA |d COCUF |d STF |d G3B |d K6U |d OCLCO |d SFB |d VVJ |d EBLCP |d OCLCA |d INARC |d UKEHC |d OCLCO |d VT2 |d OCLCO |d OCLCQ |d OCL |d OCLCQ |d QGK |d COA |d OCLCO |d OCLCL | ||
015 | |a GBA3U6208 |2 bnb | ||
016 | |a (AMICUS)000027965644 | ||
016 | 7 | |a 101161133 |2 DNLM | |
016 | 7 | |a 009703100 |2 Uk | |
019 | |a 702111913 |a 961582207 |a 962696222 |a 1053037239 |a 1125408495 |a 1128009400 |a 1136171334 |a 1165401300 |a 1200085020 |a 1259127461 |a 1286909425 |a 1340093671 | ||
020 | |a 9780262276870 |q (electronic bk.) | ||
020 | |a 0262276879 |q (electronic bk.) | ||
020 | |a 0585480184 |q (electronic bk.) | ||
020 | |a 9780585480183 |q (electronic bk.) | ||
020 | |z 0262112760 |q (hbk.) | ||
020 | |z 9780262112765 |q (hbk.) | ||
020 | |z 9780262612159 |q (pbk.) | ||
020 | |z 0262612151 |q (pbk.) | ||
024 | 8 | |a 99807933764 | |
024 | 8 | |a (WaSeSS)ssj0000112181 | |
035 | |a (OCoLC)53795840 |z (OCoLC)702111913 |z (OCoLC)961582207 |z (OCoLC)962696222 |z (OCoLC)1053037239 |z (OCoLC)1125408495 |z (OCoLC)1128009400 |z (OCoLC)1136171334 |z (OCoLC)1165401300 |z (OCoLC)1200085020 |z (OCoLC)1259127461 |z (OCoLC)1286909425 |z (OCoLC)1340093671 | ||
037 | |a 1622 |b MIT Press | ||
037 | |a 9780262276870 |b MIT Press | ||
050 | 4 | |a RA418 |b .K39 2003eb | |
055 | 0 | 1 | |a RA418 |
060 | 4 | |a 2003 M-404 | |
060 | 4 | |a WA 31 |b K25b 2003 | |
072 | 7 | |a SOC |x 002010 |2 bisacsh | |
072 | 7 | |a POL |x 038000 |2 bisacsh | |
072 | 7 | |a SOC |x 022000 |2 bisacsh | |
072 | 7 | |a coll1 |2 lacc | |
082 | 7 | |a 306.4/61 |2 22 | |
084 | |a 44.31 |2 bcl | ||
084 | |a 44.06 |2 bcl | ||
084 | |a cci1icc |2 lacc | ||
084 | |a coll1 |2 lacc | ||
084 | |a LC 56000 |2 rvk | ||
084 | |a MS 6000 |2 rvk | ||
049 | |a MAIN | ||
100 | 1 | |a Keating, Peter, |d 1953- |1 https://id.oclc.org/worldcat/entity/E39PBJhMjDChX7b7Dg3K89Xjmd |0 http://id.loc.gov/authorities/names/n95801495 | |
245 | 1 | 0 | |a Biomedical platforms : |b realigning the normal and the pathological in late-twentieth-century medicine / |c Peter Keating and Alberto Cambrosio. |
260 | |a Cambridge, Mass. : |b MIT Press, |c ©2003. | ||
300 | |a 1 online resource (xiv, 544 pages) : |b illustrations | ||
336 | |a text |b txt |2 rdacontent | ||
337 | |a computer |b c |2 rdamedia | ||
338 | |a online resource |b cr |2 rdacarrier | ||
347 | |a text file |2 rdaft | ||
490 | 1 | |a Inside technology | |
504 | |a Includes bibliographical references (pages 457-525) and index. | ||
588 | 0 | |a Print version record. | |
520 | |a Since the end of World War II, biology and medicine have merged in remarkably productive ways. In this book Peter Keating and Alberto Cambrosio analyze the transformation of medicine into biomedicine and its consequences, ranging from the recasting of hospital architecture to the redefinition of the human body, disease, and therapeutic practices. To describe this new alignment between the normal and the pathological, the authors introduce the notion of the biomedical platform. Defined as a specific configuration of instruments, individuals, and programs, biomedical platforms generate routines, entities, and activities, held together by standard reagents and protocols. Biological entities such as cell surface markers, oncogenes, and DNA profiles now exist as both normal biological components of the organism and as pathological signs--that is, as biomedical substances. The notion of a biomedical platform allows researchers interested in the development of contemporary medicine to describe events and processes overlooked by other approaches. The authors focus on a specific biomedical platform known as immunophenotyping. They describe its emergence as an experimental system with roots in biology (immunology) and pathology (oncology). They recount how this experimental system was transformed into a biomedical platform initially for the diagnosis of leukemia and subsequently for other diseases such as AIDS. Through this case study, they show that a biomedical platform is the bench upon which conventions concerning the biological or normal are connected with conventions concerning the medical or pathological. They observe that new platforms are often aligned with existing ones and integrated into an expanding set of clinical-biological strategies. | ||
505 | 0 | |a 1. An Introduction to Platforms -- 2. Hospital Platforms -- 3. Biomedicine and Platforms -- 4. Leukemia, Lymphoma, and Immunophenotyping: Building a Platform -- 5. Running the Immunophenotyping Platform -- 6. The Core of the Platform: Markers -- 7. At the Periphery: Flow and Slides -- 8. Regulating Immunophenotyping -- 9. Regulating Diseases on the Platform -- 10. Conclusion: Platform Sociology -- App. List of Interviewees. | |
546 | |a English. | ||
650 | 0 | |a Social medicine. |0 http://id.loc.gov/authorities/subjects/sh85123973 | |
650 | 0 | |a Biotechnology. |0 http://id.loc.gov/authorities/subjects/sh85014263 | |
650 | 0 | |a Biochemical markers. |0 http://id.loc.gov/authorities/subjects/sh85014122 | |
650 | 0 | |a Immunophenotyping. |0 http://id.loc.gov/authorities/subjects/sh94006122 | |
650 | 0 | |a Bioengineering. |0 http://id.loc.gov/authorities/subjects/sh85014134 | |
650 | 1 | 2 | |a Sociology, Medical |
650 | 2 | |a Biotechnology |0 https://id.nlm.nih.gov/mesh/D001709 | |
650 | 2 | |a Social Medicine |0 https://id.nlm.nih.gov/mesh/D012936 | |
650 | 2 | 2 | |a Biomarkers |
650 | 2 | 2 | |a Immunophenotyping |
650 | 6 | |a Médecine sociale. | |
650 | 6 | |a Biotechnologie. | |
650 | 6 | |a Sociologie médicale. | |
650 | 6 | |a Marqueurs biologiques. | |
650 | 6 | |a Immunophénotypage. | |
650 | 7 | |a bioengineering. |2 aat | |
650 | 7 | |a 44.06 medical sociology. |0 (NL-LeOCL)077596250 |2 bcl | |
650 | 7 | |a 44.31 medical physics. |0 (NL-LeOCL)077596404 |2 bcl | |
650 | 7 | |a SOCIAL SCIENCE |x Anthropology |x Cultural. |2 bisacsh | |
650 | 7 | |a POLITICAL SCIENCE |x Public Policy |x Cultural Policy. |2 bisacsh | |
650 | 7 | |a SOCIAL SCIENCE |x Popular Culture. |2 bisacsh | |
650 | 7 | |a Immunophenotyping |2 fast | |
650 | 7 | |a Bioengineering |2 fast | |
650 | 7 | |a Biochemical markers |2 fast | |
650 | 7 | |a Biotechnology |2 fast | |
650 | 7 | |a Social medicine |2 fast | |
650 | 7 | |a Biologie |2 gnd |0 http://d-nb.info/gnd/4006851-1 | |
650 | 7 | |a Immunphänotypisierung |2 gnd |0 http://d-nb.info/gnd/1036626768 | |
650 | 7 | |a Interdisziplinäre Forschung |2 gnd |0 http://d-nb.info/gnd/4027274-6 | |
650 | 7 | |a Krankheitsbegriff |2 gnd |0 http://d-nb.info/gnd/4125603-7 | |
650 | 7 | |a Medizin |2 gnd |0 http://d-nb.info/gnd/4038243-6 | |
650 | 7 | |a Wissenschaftlicher Fortschritt |2 gnd |0 http://d-nb.info/gnd/4190101-0 | |
650 | 1 | 7 | |a Wetenschapsdynamica. |2 gtt |
650 | 1 | 7 | |a Biotechnologie. |2 gtt |
650 | 1 | 7 | |a Biomedische techniek. |2 gtt |
650 | 1 | 7 | |a Immunologie. |0 (NL-LeOCL)078542774 |2 gtt |
650 | 1 | 7 | |a Pathologie. |2 gtt |
653 | |a SCIENCE, TECHNOLOGY & SOCIETY/General | ||
653 | |a BIOMEDICAL SCIENCES/General | ||
700 | 1 | |a Cambrosio, Alberto, |d 1950- |1 https://id.oclc.org/worldcat/entity/E39PBJmp9Q3tWb3twc87XWgFrq |0 http://id.loc.gov/authorities/names/n85068841 | |
758 | |i has work: |a Biomedical platforms (Text) |1 https://id.oclc.org/worldcat/entity/E39PCGXY7FMW394hBqG8BktGRC |4 https://id.oclc.org/worldcat/ontology/hasWork | ||
776 | 0 | 8 | |i Print version: |a Keating, Peter, 1953- |t Biomedical platforms. |d Cambridge, Mass. : MIT Press, ©2003 |z 0262112760 |w (DLC) 2002044414 |w (OCoLC)51216749 |
830 | 0 | |a Inside technology. |0 http://id.loc.gov/authorities/names/n90604147 | |
856 | 4 | 0 | |l FWS01 |p ZDB-4-EBA |q FWS_PDA_EBA |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=100074 |3 Volltext |
938 | |a ProQuest Ebook Central |b EBLB |n EBL5966289 | ||
938 | |a EBSCOhost |b EBSC |n 100074 | ||
938 | |a Internet Archive |b INAR |n biomedicalplatfo0000keat | ||
938 | |a YBP Library Services |b YANK |n 2335901 | ||
938 | |a YBP Library Services |b YANK |n 3411105 | ||
994 | |a 92 |b GEBAY | ||
912 | |a ZDB-4-EBA | ||
049 | |a DE-863 |
Datensatz im Suchindex
DE-BY-FWS_katkey | ZDB-4-EBA-ocm53795840 |
---|---|
_version_ | 1816881612517801984 |
adam_text | |
any_adam_object | |
author | Keating, Peter, 1953- |
author2 | Cambrosio, Alberto, 1950- |
author2_role | |
author2_variant | a c ac |
author_GND | http://id.loc.gov/authorities/names/n95801495 http://id.loc.gov/authorities/names/n85068841 |
author_facet | Keating, Peter, 1953- Cambrosio, Alberto, 1950- |
author_role | |
author_sort | Keating, Peter, 1953- |
author_variant | p k pk |
building | Verbundindex |
bvnumber | localFWS |
callnumber-first | R - Medicine |
callnumber-label | RA418 |
callnumber-raw | RA418 .K39 2003eb |
callnumber-search | RA418 .K39 2003eb |
callnumber-sort | RA 3418 K39 42003EB |
callnumber-subject | RA - Public Medicine |
classification_rvk | LC 56000 MS 6000 |
collection | ZDB-4-EBA |
contents | 1. An Introduction to Platforms -- 2. Hospital Platforms -- 3. Biomedicine and Platforms -- 4. Leukemia, Lymphoma, and Immunophenotyping: Building a Platform -- 5. Running the Immunophenotyping Platform -- 6. The Core of the Platform: Markers -- 7. At the Periphery: Flow and Slides -- 8. Regulating Immunophenotyping -- 9. Regulating Diseases on the Platform -- 10. Conclusion: Platform Sociology -- App. List of Interviewees. |
ctrlnum | (OCoLC)53795840 |
dewey-full | 306.4/61 |
dewey-hundreds | 300 - Social sciences |
dewey-ones | 306 - Culture and institutions |
dewey-raw | 306.4/61 |
dewey-search | 306.4/61 |
dewey-sort | 3306.4 261 |
dewey-tens | 300 - Social sciences |
discipline | Soziologie Sozial-/Kulturanthropologie / Empirische Kulturwissenschaft |
format | Electronic eBook |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>08166cam a2201297 a 4500</leader><controlfield tag="001">ZDB-4-EBA-ocm53795840 </controlfield><controlfield tag="003">OCoLC</controlfield><controlfield tag="005">20241004212047.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr cnu---unuuu</controlfield><controlfield tag="008">031126s2003 maua ob 001 0 eng d</controlfield><datafield tag="010" ind1=" " ind2=" "><subfield code="z"> 2002044414</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">N$T</subfield><subfield code="b">eng</subfield><subfield code="e">pn</subfield><subfield code="c">N$T</subfield><subfield code="d">YDXCP</subfield><subfield code="d">OCLCG</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">N$T</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCF</subfield><subfield code="d">NLGGC</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">TXHLC</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">TOA</subfield><subfield code="d">OCLCO</subfield><subfield code="d">AGLDB</subfield><subfield code="d">OCLCO</subfield><subfield code="d">JBG</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCA</subfield><subfield code="d">VNS</subfield><subfield code="d">VTS</subfield><subfield code="d">OCLCO</subfield><subfield code="d">INT</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">MITPR</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCA</subfield><subfield code="d">COCUF</subfield><subfield code="d">STF</subfield><subfield code="d">G3B</subfield><subfield code="d">K6U</subfield><subfield code="d">OCLCO</subfield><subfield code="d">SFB</subfield><subfield code="d">VVJ</subfield><subfield code="d">EBLCP</subfield><subfield code="d">OCLCA</subfield><subfield code="d">INARC</subfield><subfield code="d">UKEHC</subfield><subfield code="d">OCLCO</subfield><subfield code="d">VT2</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCL</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">QGK</subfield><subfield code="d">COA</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCL</subfield></datafield><datafield tag="015" ind1=" " ind2=" "><subfield code="a">GBA3U6208</subfield><subfield code="2">bnb</subfield></datafield><datafield tag="016" ind1=" " ind2=" "><subfield code="a">(AMICUS)000027965644</subfield></datafield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">101161133</subfield><subfield code="2">DNLM</subfield></datafield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">009703100</subfield><subfield code="2">Uk</subfield></datafield><datafield tag="019" ind1=" " ind2=" "><subfield code="a">702111913</subfield><subfield code="a">961582207</subfield><subfield code="a">962696222</subfield><subfield code="a">1053037239</subfield><subfield code="a">1125408495</subfield><subfield code="a">1128009400</subfield><subfield code="a">1136171334</subfield><subfield code="a">1165401300</subfield><subfield code="a">1200085020</subfield><subfield code="a">1259127461</subfield><subfield code="a">1286909425</subfield><subfield code="a">1340093671</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780262276870</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0262276879</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0585480184</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780585480183</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">0262112760</subfield><subfield code="q">(hbk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">9780262112765</subfield><subfield code="q">(hbk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">9780262612159</subfield><subfield code="q">(pbk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">0262612151</subfield><subfield code="q">(pbk.)</subfield></datafield><datafield tag="024" ind1="8" ind2=" "><subfield code="a">99807933764</subfield></datafield><datafield tag="024" ind1="8" ind2=" "><subfield code="a">(WaSeSS)ssj0000112181</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)53795840</subfield><subfield code="z">(OCoLC)702111913</subfield><subfield code="z">(OCoLC)961582207</subfield><subfield code="z">(OCoLC)962696222</subfield><subfield code="z">(OCoLC)1053037239</subfield><subfield code="z">(OCoLC)1125408495</subfield><subfield code="z">(OCoLC)1128009400</subfield><subfield code="z">(OCoLC)1136171334</subfield><subfield code="z">(OCoLC)1165401300</subfield><subfield code="z">(OCoLC)1200085020</subfield><subfield code="z">(OCoLC)1259127461</subfield><subfield code="z">(OCoLC)1286909425</subfield><subfield code="z">(OCoLC)1340093671</subfield></datafield><datafield tag="037" ind1=" " ind2=" "><subfield code="a">1622</subfield><subfield code="b">MIT Press</subfield></datafield><datafield tag="037" ind1=" " ind2=" "><subfield code="a">9780262276870</subfield><subfield code="b">MIT Press</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RA418</subfield><subfield code="b">.K39 2003eb</subfield></datafield><datafield tag="055" ind1="0" ind2="1"><subfield code="a">RA418</subfield></datafield><datafield tag="060" ind1=" " ind2="4"><subfield code="a">2003 M-404</subfield></datafield><datafield tag="060" ind1=" " ind2="4"><subfield code="a">WA 31</subfield><subfield code="b">K25b 2003</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">SOC</subfield><subfield code="x">002010</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">POL</subfield><subfield code="x">038000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">SOC</subfield><subfield code="x">022000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">coll1</subfield><subfield code="2">lacc</subfield></datafield><datafield tag="082" ind1="7" ind2=" "><subfield code="a">306.4/61</subfield><subfield code="2">22</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.31</subfield><subfield code="2">bcl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.06</subfield><subfield code="2">bcl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">cci1icc</subfield><subfield code="2">lacc</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">coll1</subfield><subfield code="2">lacc</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">LC 56000</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">MS 6000</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">MAIN</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Keating, Peter,</subfield><subfield code="d">1953-</subfield><subfield code="1">https://id.oclc.org/worldcat/entity/E39PBJhMjDChX7b7Dg3K89Xjmd</subfield><subfield code="0">http://id.loc.gov/authorities/names/n95801495</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Biomedical platforms :</subfield><subfield code="b">realigning the normal and the pathological in late-twentieth-century medicine /</subfield><subfield code="c">Peter Keating and Alberto Cambrosio.</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Cambridge, Mass. :</subfield><subfield code="b">MIT Press,</subfield><subfield code="c">©2003.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (xiv, 544 pages) :</subfield><subfield code="b">illustrations</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="347" ind1=" " ind2=" "><subfield code="a">text file</subfield><subfield code="2">rdaft</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Inside technology</subfield></datafield><datafield tag="504" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references (pages 457-525) and index.</subfield></datafield><datafield tag="588" ind1="0" ind2=" "><subfield code="a">Print version record.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Since the end of World War II, biology and medicine have merged in remarkably productive ways. In this book Peter Keating and Alberto Cambrosio analyze the transformation of medicine into biomedicine and its consequences, ranging from the recasting of hospital architecture to the redefinition of the human body, disease, and therapeutic practices. To describe this new alignment between the normal and the pathological, the authors introduce the notion of the biomedical platform. Defined as a specific configuration of instruments, individuals, and programs, biomedical platforms generate routines, entities, and activities, held together by standard reagents and protocols. Biological entities such as cell surface markers, oncogenes, and DNA profiles now exist as both normal biological components of the organism and as pathological signs--that is, as biomedical substances. The notion of a biomedical platform allows researchers interested in the development of contemporary medicine to describe events and processes overlooked by other approaches. The authors focus on a specific biomedical platform known as immunophenotyping. They describe its emergence as an experimental system with roots in biology (immunology) and pathology (oncology). They recount how this experimental system was transformed into a biomedical platform initially for the diagnosis of leukemia and subsequently for other diseases such as AIDS. Through this case study, they show that a biomedical platform is the bench upon which conventions concerning the biological or normal are connected with conventions concerning the medical or pathological. They observe that new platforms are often aligned with existing ones and integrated into an expanding set of clinical-biological strategies.</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">1. An Introduction to Platforms -- 2. Hospital Platforms -- 3. Biomedicine and Platforms -- 4. Leukemia, Lymphoma, and Immunophenotyping: Building a Platform -- 5. Running the Immunophenotyping Platform -- 6. The Core of the Platform: Markers -- 7. At the Periphery: Flow and Slides -- 8. Regulating Immunophenotyping -- 9. Regulating Diseases on the Platform -- 10. Conclusion: Platform Sociology -- App. List of Interviewees.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Social medicine.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85123973</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Biotechnology.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85014263</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Biochemical markers.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85014122</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Immunophenotyping.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh94006122</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Bioengineering.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85014134</subfield></datafield><datafield tag="650" ind1="1" ind2="2"><subfield code="a">Sociology, Medical</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Biotechnology</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D001709</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Social Medicine</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D012936</subfield></datafield><datafield tag="650" ind1="2" ind2="2"><subfield code="a">Biomarkers</subfield></datafield><datafield tag="650" ind1="2" ind2="2"><subfield code="a">Immunophenotyping</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Médecine sociale.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Biotechnologie.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Sociologie médicale.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Marqueurs biologiques.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Immunophénotypage.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">bioengineering.</subfield><subfield code="2">aat</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">44.06 medical sociology.</subfield><subfield code="0">(NL-LeOCL)077596250</subfield><subfield code="2">bcl</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">44.31 medical physics.</subfield><subfield code="0">(NL-LeOCL)077596404</subfield><subfield code="2">bcl</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">SOCIAL SCIENCE</subfield><subfield code="x">Anthropology</subfield><subfield code="x">Cultural.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">POLITICAL SCIENCE</subfield><subfield code="x">Public Policy</subfield><subfield code="x">Cultural Policy.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">SOCIAL SCIENCE</subfield><subfield code="x">Popular Culture.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Immunophenotyping</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Bioengineering</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Biochemical markers</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Biotechnology</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Social medicine</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Biologie</subfield><subfield code="2">gnd</subfield><subfield code="0">http://d-nb.info/gnd/4006851-1</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Immunphänotypisierung</subfield><subfield code="2">gnd</subfield><subfield code="0">http://d-nb.info/gnd/1036626768</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Interdisziplinäre Forschung</subfield><subfield code="2">gnd</subfield><subfield code="0">http://d-nb.info/gnd/4027274-6</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Krankheitsbegriff</subfield><subfield code="2">gnd</subfield><subfield code="0">http://d-nb.info/gnd/4125603-7</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Medizin</subfield><subfield code="2">gnd</subfield><subfield code="0">http://d-nb.info/gnd/4038243-6</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Wissenschaftlicher Fortschritt</subfield><subfield code="2">gnd</subfield><subfield code="0">http://d-nb.info/gnd/4190101-0</subfield></datafield><datafield tag="650" ind1="1" ind2="7"><subfield code="a">Wetenschapsdynamica.</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1="1" ind2="7"><subfield code="a">Biotechnologie.</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1="1" ind2="7"><subfield code="a">Biomedische techniek.</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1="1" ind2="7"><subfield code="a">Immunologie.</subfield><subfield code="0">(NL-LeOCL)078542774</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1="1" ind2="7"><subfield code="a">Pathologie.</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">SCIENCE, TECHNOLOGY & SOCIETY/General</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">BIOMEDICAL SCIENCES/General</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cambrosio, Alberto,</subfield><subfield code="d">1950-</subfield><subfield code="1">https://id.oclc.org/worldcat/entity/E39PBJmp9Q3tWb3twc87XWgFrq</subfield><subfield code="0">http://id.loc.gov/authorities/names/n85068841</subfield></datafield><datafield tag="758" ind1=" " ind2=" "><subfield code="i">has work:</subfield><subfield code="a">Biomedical platforms (Text)</subfield><subfield code="1">https://id.oclc.org/worldcat/entity/E39PCGXY7FMW394hBqG8BktGRC</subfield><subfield code="4">https://id.oclc.org/worldcat/ontology/hasWork</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Print version:</subfield><subfield code="a">Keating, Peter, 1953-</subfield><subfield code="t">Biomedical platforms.</subfield><subfield code="d">Cambridge, Mass. : MIT Press, ©2003</subfield><subfield code="z">0262112760</subfield><subfield code="w">(DLC) 2002044414</subfield><subfield code="w">(OCoLC)51216749</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Inside technology.</subfield><subfield code="0">http://id.loc.gov/authorities/names/n90604147</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="l">FWS01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FWS_PDA_EBA</subfield><subfield code="u">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=100074</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">ProQuest Ebook Central</subfield><subfield code="b">EBLB</subfield><subfield code="n">EBL5966289</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">EBSCOhost</subfield><subfield code="b">EBSC</subfield><subfield code="n">100074</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">Internet Archive</subfield><subfield code="b">INAR</subfield><subfield code="n">biomedicalplatfo0000keat</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">YBP Library Services</subfield><subfield code="b">YANK</subfield><subfield code="n">2335901</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">YBP Library Services</subfield><subfield code="b">YANK</subfield><subfield code="n">3411105</subfield></datafield><datafield tag="994" ind1=" " ind2=" "><subfield code="a">92</subfield><subfield code="b">GEBAY</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-863</subfield></datafield></record></collection> |
id | ZDB-4-EBA-ocm53795840 |
illustrated | Illustrated |
indexdate | 2024-11-27T13:15:29Z |
institution | BVB |
isbn | 9780262276870 0262276879 0585480184 9780585480183 |
language | English |
oclc_num | 53795840 |
open_access_boolean | |
owner | MAIN DE-863 DE-BY-FWS |
owner_facet | MAIN DE-863 DE-BY-FWS |
physical | 1 online resource (xiv, 544 pages) : illustrations |
psigel | ZDB-4-EBA |
publishDate | 2003 |
publishDateSearch | 2003 |
publishDateSort | 2003 |
publisher | MIT Press, |
record_format | marc |
series | Inside technology. |
series2 | Inside technology |
spelling | Keating, Peter, 1953- https://id.oclc.org/worldcat/entity/E39PBJhMjDChX7b7Dg3K89Xjmd http://id.loc.gov/authorities/names/n95801495 Biomedical platforms : realigning the normal and the pathological in late-twentieth-century medicine / Peter Keating and Alberto Cambrosio. Cambridge, Mass. : MIT Press, ©2003. 1 online resource (xiv, 544 pages) : illustrations text txt rdacontent computer c rdamedia online resource cr rdacarrier text file rdaft Inside technology Includes bibliographical references (pages 457-525) and index. Print version record. Since the end of World War II, biology and medicine have merged in remarkably productive ways. In this book Peter Keating and Alberto Cambrosio analyze the transformation of medicine into biomedicine and its consequences, ranging from the recasting of hospital architecture to the redefinition of the human body, disease, and therapeutic practices. To describe this new alignment between the normal and the pathological, the authors introduce the notion of the biomedical platform. Defined as a specific configuration of instruments, individuals, and programs, biomedical platforms generate routines, entities, and activities, held together by standard reagents and protocols. Biological entities such as cell surface markers, oncogenes, and DNA profiles now exist as both normal biological components of the organism and as pathological signs--that is, as biomedical substances. The notion of a biomedical platform allows researchers interested in the development of contemporary medicine to describe events and processes overlooked by other approaches. The authors focus on a specific biomedical platform known as immunophenotyping. They describe its emergence as an experimental system with roots in biology (immunology) and pathology (oncology). They recount how this experimental system was transformed into a biomedical platform initially for the diagnosis of leukemia and subsequently for other diseases such as AIDS. Through this case study, they show that a biomedical platform is the bench upon which conventions concerning the biological or normal are connected with conventions concerning the medical or pathological. They observe that new platforms are often aligned with existing ones and integrated into an expanding set of clinical-biological strategies. 1. An Introduction to Platforms -- 2. Hospital Platforms -- 3. Biomedicine and Platforms -- 4. Leukemia, Lymphoma, and Immunophenotyping: Building a Platform -- 5. Running the Immunophenotyping Platform -- 6. The Core of the Platform: Markers -- 7. At the Periphery: Flow and Slides -- 8. Regulating Immunophenotyping -- 9. Regulating Diseases on the Platform -- 10. Conclusion: Platform Sociology -- App. List of Interviewees. English. Social medicine. http://id.loc.gov/authorities/subjects/sh85123973 Biotechnology. http://id.loc.gov/authorities/subjects/sh85014263 Biochemical markers. http://id.loc.gov/authorities/subjects/sh85014122 Immunophenotyping. http://id.loc.gov/authorities/subjects/sh94006122 Bioengineering. http://id.loc.gov/authorities/subjects/sh85014134 Sociology, Medical Biotechnology https://id.nlm.nih.gov/mesh/D001709 Social Medicine https://id.nlm.nih.gov/mesh/D012936 Biomarkers Immunophenotyping Médecine sociale. Biotechnologie. Sociologie médicale. Marqueurs biologiques. Immunophénotypage. bioengineering. aat 44.06 medical sociology. (NL-LeOCL)077596250 bcl 44.31 medical physics. (NL-LeOCL)077596404 bcl SOCIAL SCIENCE Anthropology Cultural. bisacsh POLITICAL SCIENCE Public Policy Cultural Policy. bisacsh SOCIAL SCIENCE Popular Culture. bisacsh Immunophenotyping fast Bioengineering fast Biochemical markers fast Biotechnology fast Social medicine fast Biologie gnd http://d-nb.info/gnd/4006851-1 Immunphänotypisierung gnd http://d-nb.info/gnd/1036626768 Interdisziplinäre Forschung gnd http://d-nb.info/gnd/4027274-6 Krankheitsbegriff gnd http://d-nb.info/gnd/4125603-7 Medizin gnd http://d-nb.info/gnd/4038243-6 Wissenschaftlicher Fortschritt gnd http://d-nb.info/gnd/4190101-0 Wetenschapsdynamica. gtt Biotechnologie. gtt Biomedische techniek. gtt Immunologie. (NL-LeOCL)078542774 gtt Pathologie. gtt SCIENCE, TECHNOLOGY & SOCIETY/General BIOMEDICAL SCIENCES/General Cambrosio, Alberto, 1950- https://id.oclc.org/worldcat/entity/E39PBJmp9Q3tWb3twc87XWgFrq http://id.loc.gov/authorities/names/n85068841 has work: Biomedical platforms (Text) https://id.oclc.org/worldcat/entity/E39PCGXY7FMW394hBqG8BktGRC https://id.oclc.org/worldcat/ontology/hasWork Print version: Keating, Peter, 1953- Biomedical platforms. Cambridge, Mass. : MIT Press, ©2003 0262112760 (DLC) 2002044414 (OCoLC)51216749 Inside technology. http://id.loc.gov/authorities/names/n90604147 FWS01 ZDB-4-EBA FWS_PDA_EBA https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=100074 Volltext |
spellingShingle | Keating, Peter, 1953- Biomedical platforms : realigning the normal and the pathological in late-twentieth-century medicine / Inside technology. 1. An Introduction to Platforms -- 2. Hospital Platforms -- 3. Biomedicine and Platforms -- 4. Leukemia, Lymphoma, and Immunophenotyping: Building a Platform -- 5. Running the Immunophenotyping Platform -- 6. The Core of the Platform: Markers -- 7. At the Periphery: Flow and Slides -- 8. Regulating Immunophenotyping -- 9. Regulating Diseases on the Platform -- 10. Conclusion: Platform Sociology -- App. List of Interviewees. Social medicine. http://id.loc.gov/authorities/subjects/sh85123973 Biotechnology. http://id.loc.gov/authorities/subjects/sh85014263 Biochemical markers. http://id.loc.gov/authorities/subjects/sh85014122 Immunophenotyping. http://id.loc.gov/authorities/subjects/sh94006122 Bioengineering. http://id.loc.gov/authorities/subjects/sh85014134 Sociology, Medical Biotechnology https://id.nlm.nih.gov/mesh/D001709 Social Medicine https://id.nlm.nih.gov/mesh/D012936 Biomarkers Immunophenotyping Médecine sociale. Biotechnologie. Sociologie médicale. Marqueurs biologiques. Immunophénotypage. bioengineering. aat 44.06 medical sociology. (NL-LeOCL)077596250 bcl 44.31 medical physics. (NL-LeOCL)077596404 bcl SOCIAL SCIENCE Anthropology Cultural. bisacsh POLITICAL SCIENCE Public Policy Cultural Policy. bisacsh SOCIAL SCIENCE Popular Culture. bisacsh Immunophenotyping fast Bioengineering fast Biochemical markers fast Biotechnology fast Social medicine fast Biologie gnd http://d-nb.info/gnd/4006851-1 Immunphänotypisierung gnd http://d-nb.info/gnd/1036626768 Interdisziplinäre Forschung gnd http://d-nb.info/gnd/4027274-6 Krankheitsbegriff gnd http://d-nb.info/gnd/4125603-7 Medizin gnd http://d-nb.info/gnd/4038243-6 Wissenschaftlicher Fortschritt gnd http://d-nb.info/gnd/4190101-0 Wetenschapsdynamica. gtt Biotechnologie. gtt Biomedische techniek. gtt Immunologie. (NL-LeOCL)078542774 gtt Pathologie. gtt |
subject_GND | http://id.loc.gov/authorities/subjects/sh85123973 http://id.loc.gov/authorities/subjects/sh85014263 http://id.loc.gov/authorities/subjects/sh85014122 http://id.loc.gov/authorities/subjects/sh94006122 http://id.loc.gov/authorities/subjects/sh85014134 https://id.nlm.nih.gov/mesh/D001709 https://id.nlm.nih.gov/mesh/D012936 (NL-LeOCL)077596250 (NL-LeOCL)077596404 http://d-nb.info/gnd/4006851-1 http://d-nb.info/gnd/1036626768 http://d-nb.info/gnd/4027274-6 http://d-nb.info/gnd/4125603-7 http://d-nb.info/gnd/4038243-6 http://d-nb.info/gnd/4190101-0 (NL-LeOCL)078542774 |
title | Biomedical platforms : realigning the normal and the pathological in late-twentieth-century medicine / |
title_auth | Biomedical platforms : realigning the normal and the pathological in late-twentieth-century medicine / |
title_exact_search | Biomedical platforms : realigning the normal and the pathological in late-twentieth-century medicine / |
title_full | Biomedical platforms : realigning the normal and the pathological in late-twentieth-century medicine / Peter Keating and Alberto Cambrosio. |
title_fullStr | Biomedical platforms : realigning the normal and the pathological in late-twentieth-century medicine / Peter Keating and Alberto Cambrosio. |
title_full_unstemmed | Biomedical platforms : realigning the normal and the pathological in late-twentieth-century medicine / Peter Keating and Alberto Cambrosio. |
title_short | Biomedical platforms : |
title_sort | biomedical platforms realigning the normal and the pathological in late twentieth century medicine |
title_sub | realigning the normal and the pathological in late-twentieth-century medicine / |
topic | Social medicine. http://id.loc.gov/authorities/subjects/sh85123973 Biotechnology. http://id.loc.gov/authorities/subjects/sh85014263 Biochemical markers. http://id.loc.gov/authorities/subjects/sh85014122 Immunophenotyping. http://id.loc.gov/authorities/subjects/sh94006122 Bioengineering. http://id.loc.gov/authorities/subjects/sh85014134 Sociology, Medical Biotechnology https://id.nlm.nih.gov/mesh/D001709 Social Medicine https://id.nlm.nih.gov/mesh/D012936 Biomarkers Immunophenotyping Médecine sociale. Biotechnologie. Sociologie médicale. Marqueurs biologiques. Immunophénotypage. bioengineering. aat 44.06 medical sociology. (NL-LeOCL)077596250 bcl 44.31 medical physics. (NL-LeOCL)077596404 bcl SOCIAL SCIENCE Anthropology Cultural. bisacsh POLITICAL SCIENCE Public Policy Cultural Policy. bisacsh SOCIAL SCIENCE Popular Culture. bisacsh Immunophenotyping fast Bioengineering fast Biochemical markers fast Biotechnology fast Social medicine fast Biologie gnd http://d-nb.info/gnd/4006851-1 Immunphänotypisierung gnd http://d-nb.info/gnd/1036626768 Interdisziplinäre Forschung gnd http://d-nb.info/gnd/4027274-6 Krankheitsbegriff gnd http://d-nb.info/gnd/4125603-7 Medizin gnd http://d-nb.info/gnd/4038243-6 Wissenschaftlicher Fortschritt gnd http://d-nb.info/gnd/4190101-0 Wetenschapsdynamica. gtt Biotechnologie. gtt Biomedische techniek. gtt Immunologie. (NL-LeOCL)078542774 gtt Pathologie. gtt |
topic_facet | Social medicine. Biotechnology. Biochemical markers. Immunophenotyping. Bioengineering. Sociology, Medical Biotechnology Social Medicine Biomarkers Immunophenotyping Médecine sociale. Biotechnologie. Sociologie médicale. Marqueurs biologiques. Immunophénotypage. bioengineering. 44.06 medical sociology. 44.31 medical physics. SOCIAL SCIENCE Anthropology Cultural. POLITICAL SCIENCE Public Policy Cultural Policy. SOCIAL SCIENCE Popular Culture. Bioengineering Biochemical markers Social medicine Biologie Immunphänotypisierung Interdisziplinäre Forschung Krankheitsbegriff Medizin Wissenschaftlicher Fortschritt Wetenschapsdynamica. Biomedische techniek. Immunologie. Pathologie. |
url | https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=100074 |
work_keys_str_mv | AT keatingpeter biomedicalplatformsrealigningthenormalandthepathologicalinlatetwentiethcenturymedicine AT cambrosioalberto biomedicalplatformsrealigningthenormalandthepathologicalinlatetwentiethcenturymedicine |